Specific immunotherapy can greatly reduce the need for systemic steroids in allergic rhinitis
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Worldwide, more than 400 million individuals have allergic rhinitis, which has a significant impact on the individual's general health. Most patients self-medicate with over-the-counter drugs, but severe cases need treatment with topical corticosteroids and/or immunotherapy (SCIT). Although the ARIA guidelines discourage the use of systemic corticosteroids, this treatment is often used by general practitioners.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Allergy: European Journal of Allergy and Clinical Immunology |
Vol/bind | 67 |
Udgave nummer | 11 |
Sider (fra-til) | 1423-9 |
Antal sider | 7 |
ISSN | 0105-4538 |
DOI | |
Status | Udgivet - 2012 |
ID: 48420676